Much of the tobacco industry is looking at Philip Morris International’s iQOS product, which has a MRTP application that is currently under review by the FDA. If granted, iQOS will be able to be marketed as a reduced-risk product in the U.S. and could set a precedent for other products in that category to receive similar classification and consideration.
To read the full report from Convenience Store News, click here.
